70 related articles for article (PubMed ID: 696185)
21. Production of human chorionic gonadotropin during the normal menstrual cycle.
Cole LA; Gutierrez JM
J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
[TBL] [Abstract][Full Text] [Related]
22. Intrauterine device termination rates and the menstrual cycle day of insertion.
White MK; Ory HW; Rooks JB; Rochat RW
Obstet Gynecol; 1980 Feb; 55(2):220-4. PubMed ID: 7352085
[TBL] [Abstract][Full Text] [Related]
23. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
[TBL] [Abstract][Full Text] [Related]
24. Efficiency and acceptability of intrauterine contraceptive devices.
Trutko NS
Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154
[TBL] [Abstract][Full Text] [Related]
25. Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
Sharpe RM; Wrixon W; Hobson BM; Corker CS; McLean HA; Short RV
J Clin Endocrinol Metab; 1977 Sep; 45(3):496-9. PubMed ID: 903400
[TBL] [Abstract][Full Text] [Related]
26. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
27. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
28. Measurement of plasma human chorionic gonadotropin (hCG) and beta-hCG activities in the late luteal phase: evidence of the occurrence of spontaneous menstrual abortions in infertile women.
Chartier M; Roger M; Barrat J; Michelon B
Fertil Steril; 1979 Feb; 31(2):134-7. PubMed ID: 761674
[TBL] [Abstract][Full Text] [Related]
29. Rapid hCG-specific radioimmunoassay for menstrual aspiration.
Kosasa TS; Pion RJ; Hale RW; Goldstein DP; Taymor ML; Levesque LA; Kobara TY
Obstet Gynecol; 1975 May; 45(5):566-8. PubMed ID: 1124174
[TBL] [Abstract][Full Text] [Related]
30. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
Brenner PF; Mishell DR
Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of pregnancy-specific beta 1-glycoprotein (SP1) and human chorionic gonadotropin (beta-hCG) in women using an intrauterine device.
Tamsen L; Eneroth P
Contraception; 1986 May; 33(5):497-501. PubMed ID: 2428559
[TBL] [Abstract][Full Text] [Related]
33. Human chorionic gonadotropin beta-subunit--like immunoreactive material in the plasma of women wearing an intrauterine progesterone contraceptive system.
Orloff VS; Yamamoto S; Greenwood FC; Bryant-Greenwood GD
Am J Obstet Gynecol; 1979 Jul; 134(6):632-7. PubMed ID: 463954
[TBL] [Abstract][Full Text] [Related]
34. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
35. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
Güney M; Oral B; Karahan N; Mungan T
Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
[TBL] [Abstract][Full Text] [Related]
36. Long-term cytologic studies of copper-IUD users.
Engineer AD; Misra JS; Tandon P
Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the beta-Neocept test for early pregnancy.
Yuen BH; Pride SM; Callegari PB
Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
[TBL] [Abstract][Full Text] [Related]
38. Transitory hCG-like activity in the urine of some IUD users.
Hodgen GD; Chen HC; Dufau ML; Klein TA; Mishell DR
J Clin Endocrinol Metab; 1978 Apr; 46(4):698-701. PubMed ID: 755054
[TBL] [Abstract][Full Text] [Related]
39. The normal variabilities of the menstrual cycle.
Cole LA; Ladner DG; Byrn FW
Fertil Steril; 2009 Feb; 91(2):522-7. PubMed ID: 18433748
[TBL] [Abstract][Full Text] [Related]
40. Measurement of human luteinizing hormone in plasma by radioimmunoassay.
Schalch DS; Parlow AF; Boon RC; Reichlin S
J Clin Invest; 1968 Mar; 47(3):665-78. PubMed ID: 4295312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
